Showing results (1261-1270 of 1,332) with videos related to

Sort By:
Pageof 134
Gastroenterology|May 6, 2014
Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancerYanxin Luo, Chao-Jen Wong, Andrew M Kaz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic CholangiocarcinomaShuling Chen, Yubin Xie, Yuhong Cai, et al.
British Journal of Cancer|July 30, 2020
Association between adjuvant chemotherapy and survival in patients with rectal cancer and pathological complete response after neoadjuvant chemoradiotherapy and resectionFang He, Huai-Qiang Ju, Yi Ding, et al.
Clinical Colorectal Cancer|August 6, 2019
Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal CancerJianwei Zhang, Meijin Huang, Yue Cai, et al.
NAR Genomics and Bioinformatics|August 8, 2022
Mining bacterial NGS data vastly expands the complete genomes of temperate phagesXianglilan Zhang, Ruohan Wang, Xiangcheng Xie, et al.
Journal of Medicinal Chemistry|October 5, 2018
Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of ActionXingchun Han, Chengang Zhou, Min Jiang, et al.
Angewandte Chemie (International Ed. in English)|March 25, 2025
Cooperative Redox Reactions Encoded by Two Gene Clusters Enable Intermolecular Cycloaddition Cascade for the Formation of MeroaspochalasinsPengkun Li, Jie Meng, Xiaotian Zhang, et al.
The Lancet. Haematology|May 30, 2020
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trialsSaad Z Usmani, Hareth Nahi, Torben Plesner, et al.
The Lancet. Haematology|October 4, 2023
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trialMeletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Journal of Hepatology|February 8, 2024
Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapyRong Xiao, Ye Tian, Jiwei Zhang, et al.
Pageof 134